Galapagos NV
GLPG
$24.11
-$0.39-1.59%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/28/2025
-
TipRanks Financial Blog
3/27/2025
-
Globe Newswire
3/20/2025
-
Ticker Report
3/18/2025
-
MarketBeat
3/14/2025
-
Ticker Report
3/4/2025
-
MarketBeat
2/20/2025
-
MarketBeat
2/19/2025
-
MarketBeat
2/18/2025
-
Market News Video
2/18/2025
-
Ticker Report
2/17/2025
-
TipRanks Financial Blog
2/15/2025
-
GuruFocus
2/15/2025
-
MarketBeat
2/14/2025
-
MarketBeat
2/14/2025
-
GuruFocus
2/14/2025
-
GuruFocus
2/13/2025
-
Seeking Alpha: Transcripts
2/13/2025
-
SeekingAlpha
2/13/2025
-
SeekingAlpha
2/10/2025
-
MarketBeat
2/7/2025
-
MarketBeat
2/5/2025
-
Ticker Report
2/4/2025
-
Ticker Report
2/3/2025
-
MarketBeat
1/28/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, March 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
32 1 534 29 00
Address
Generaal De Wittelaan L11 A3
Mechelen, 2800
Mechelen, 2800
Country
Year Founded
Business Description
Sector
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667 that has...
more
